tiprankstipranks
Entero Therapeutics (ENTO)
NASDAQ:ENTO
US Market

Entero Therapeutics (ENTO) Financial Statements

1,209 Followers

Entero Therapeutics Financial Overview

Entero Therapeutics's market cap is currently ―. The company's EPS TTM is $-49.226; its P/E ratio is -0.02; Entero Therapeutics is scheduled to report earnings on August 13, 2019, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue---$ -595.00K$ 0.00
Gross Profit---$ -595.00K-
EBIT$ -3.43M$ -4.18M$ -4.06M$ -561.74K$ 4.39M
EBITDA$ -3.43M$ -4.18M$ -4.05M$ -554.42K$ 4.40M
Net Income Common Stockholders$ -3.48M$ -4.28M$ -4.16M$ -1.63M$ 4.23M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.29M$ 1.24M$ 2.06M$ 1.36M$ 1.66M
Total Assets$ 5.93M$ 4.33M$ 5.50M$ 5.44M$ 4.65M
Total Debt$ 231.29K$ 401.70K$ 644.85K$ 883.71K$ 295.69K
Net Debt$ -3.06M$ -834.35K$ -1.42M$ -479.20K$ -1.36M
Total Liabilities$ 2.65M$ 3.45M$ 2.82M$ 2.70M$ 6.93M
Stockholders Equity$ 3.28M$ 881.96K$ 2.71M$ 2.74M$ -2.28M
Cash Flow-
Free Cash Flow$ -3.33M$ -2.76M$ -2.85M$ -5.59M$ -4.25M
Operating Cash Flow$ -3.33M$ -2.76M$ -2.85M$ -5.59M$ -4.25M
Investing Cash Flow----$ 0.00
Financing Cash Flow$ 5.39M$ 1.93M$ 3.55M$ 5.52M$ 4.77M
Currency in USD

Entero Therapeutics Earnings and Revenue History

Entero Therapeutics Debt to Assets

Entero Therapeutics Cash Flow

Entero Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis